In contrast, studies by D. Wang et al. and Y. Yang et al. demonstrated that CAR-CD4+ T cells alone outperformed both CD8+ T cells and mixed products in models of glioblastoma and leukemia [10, 22]. This evidence concerns the gene CD8A and leukemia.